The shareholder hurdle is cleared, modestly better than a failed-vote risk. Holders representing 89.77% of eligible shares attended the Scheme Meeting, and the proposal met both the required shareholder-count and 75%-by-value tests. 〔0〕 That is meaningful progress, but this was a scheduled approval step rather than a financial surprise, so the read is procedural rather than a major earnings catalyst.
The filing advances the redomestication but does not complete it. The approved package would replace Irish ordinary shares with common stock of a Delaware corporation and authorizes the related share cancellation, reissuance, and articles amendments. 〔1〕 The remaining gating item is sanction by the High Court of Ireland. 〔2〕
Net: a slight positive de-risking event, not value realization. Management still targets completion in the fourth quarter of 2026, but the filing provides no quantified savings, tax benefit, capital-allocation change, or operating impact. 〔3〕 The market can now focus on court approval and execution; until then, the expected benefits remain prospective rather than delivered.
Read the original 8-K on SEC EDGAR ↗